中国全科医学2024，Vol.27Issue(29)：3581-3586,6.DOI:10.12114/j.issn.1007-9572.2024.0149
2023年美国预防临床服务指南工作组《妊娠期高血压疾病筛查》推荐声明解读
Interpretation of the 2023 Recommendation Statement by the U.S.Preventive Services Task Force on the Screening for Hypertensive Disorders of Pregnancy
摘要
Abstract
Hypertensive disorders of pregnancy(HDP)is one of the leading causes of maternal and perinatal mortality worldwide,with increasing incidence and mortality year by year.In 2023,the U.S.Preventive Services Task Force(USPSTF)updated the recommendation statement on screening for hypertensive disorders of pregnancy by evaluating the latest research evidence and analyzing the benefits and harms of screening for HDP.The recommendation,compared with the 2017 version,further affirms the importance of blood pressure measurement in screening for HDP,affirms substantial net benefit,and recommends blood pressure measurement throughout pregnancy to screen for HDP.This article explores and analyzes the key points of this recommendation based on the RIGHT statement for introductions and interpretations of guidelines in Chinese(RIGHT for INT)and its implications for guiding general practitioners in China.关键词
妊娠期高血压疾病/筛查/指南解读/美国预防临床服务指南工作组Key words
Hypertensive disorders of pregnancy/Screening/Guideline interpretation/U.S.Preventive Services Task Force分类
医药卫生引用本文复制引用
张鹏,廖晓阳,刘力滴,杨梓钰,杨荣,吕垚,周伊恒,方湘,雷弋,代华..2023年美国预防临床服务指南工作组《妊娠期高血压疾病筛查》推荐声明解读[J].中国全科医学,2024,27(29):3581-3586,6.基金项目
四川省科技厅软科学项目(2022JDR0325) （2022JDR0325）
